News 12 Hudson Valley |
Ed Diana has liver
Times Herald-Record Click here to load this Caspio Online Database. Deputy Orange County Executive Steven Gross updates local media Sunday on the health of Orange County Executive Edward Diana after the county executive underwent liver transplant surgery on Saturday. County Executive Diana is recoveringThe Chronicle Diana’s liver transplant is a successMid-Hudson News Orange County’s top official receives liver transplantEmpireStateNews.net |
Abcam's New Alexa Fluor Secondary Antibodies Provide Increased Selection for … – SelectScience.net (press release)
|
Abcam’s New Alexa Fluor Secondary Antibodies Provide Increased Selection for …
SelectScience.net (press release) Abcam Plc., a leading provider of protein research tools and services, announced today that it has added new Alexa Fluor® 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor® 488/555/594/647 conjugates. Extensively tested in Abcam’s … |
Speaker's Corner: Legal community urged to foster volunteerism, organ donation – Law Times
|
Speaker’s Corner: Legal community urged to foster volunteerism, organ donation
Law Times If people knew how important this is and how easy it is to register to be an organ donor, they would agree to do it. They also need to know that for those left behind, organ donation can provide comfort as they grieve their loss. Miriam Young … |
Diagenode Launches Extensively Validated Epigenetic Antibodies for Broad … – PR Web (press release)
|
Diagenode Launches Extensively Validated Epigenetic Antibodies for Broad …
PR Web (press release) Liège, Belgium (PRWEB) November 04, 2013 — Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, recently launched its “Premium” line of antibodies for epigenetics applications such as chromatin immunoprecipitation … |
Sugar intake not linked with liver disease – Times of India
Times of IndiaSugar intake not linked with liver diseaseTimes of IndiaHowever, in the weight-gaining period, both diets produced equivalent features of nonalcoholic fatty liver disease, including steatosis (fatty liver) and elevated serum transaminase …
New HIV antibodies show profound impact – Press TV
Press TV |
New HIV antibodies show profound impact
Press TV Researchers have discovered potent antibodies reported to have antiviral therapeutic effect in wiping immunodeficiency viruses in patients with HIV. According to the study on animals, the discovered antibodies are able to remove a blend of human and … HIV antibodies ‘have potent impact’The Standard Digital News Studying Monkeys in Search for Human HIV CureOnislam.net New research could ‘revolutionise’ HIV treatmentInternational Federation of Gynecology and Obstetrics R & D Magazine –South China Morning Post all 8 news articles » |
IL-17 antibodies gain momentum – Nature.com
|
IL-17 antibodies gain momentum
Nature.com In pursuit are Amgen and Eli Lilly and Company, which also have IL-17-targeting monoclonal antibodies (mAbs) in Phase III development for psoriasis. Amgen’s brodalumab and Lilly’s ixekizumab both achieved similar efficacy as secukinumab in Phase II … |
Heart transplant patients survive thanks to new devices, drugs – Killeen Daily Herald
Heart transplant patients survive thanks to new devices, drugsKilleen Daily HeraldHeart transplant. Implanted devices helped keep Chris Einhorn active for 17 months until she had heart transplant surgery in August. She was able to leave the hospital ni…
New drug could potentially treat lung cancer – Times of India
Times of IndiaNew drug could potentially treat lung cancerTimes of IndiaLOS ANGELES: An new experimental drug that has shown promise in the treatment of melanoma may potentially treat patients with a most common form of lung cancer, scientists say. The…
AIMM Therapeutics‚Äô Pre-fusion RSV Antibodies Facilitate Improved Approach … – PharmiWeb.com (press release)
|
AIMM Therapeutics‚Äô Pre-fusion RSV Antibodies Facilitate Improved Approach …
PharmiWeb.com (press release) AIMM Therapeutics B.V. a leading developer of a new generation of therapeutic antibodies announced today that researchers have used the Company‚Äôs unique family of antibodies that neutralize respiratory syncytial virus (RSV) to engineer an improved … |